METALLOPROTEINASE-CLEAVABLE ALPHA-AMANITIN-DENDRIMER CONJUGATES AND METHOD OF TREATING CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160220687A1
SERIAL NO

15011169

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A conjugate comprising a dendritic polymer or other scaffold, a metalloproteinase-cleavable linker and alpha-amanitin. Methods of using this conjugate for safe targeted treatment of cancer cells expressing metalloproteinases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTERKING ABDULAZIZ MEDICAL CITY - RIYADH P O BOX 22490 RIYADH 11426
KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCESKING ABDULAZIZ MEDICAL CITY - RIYADH P O BOX 22490 RIYADH 11426
NATIONAL GUARD HEALTH AFFAIRSKING ABDULAZIZ MEDICAL CITY - RIYADH P O BOX 22490 RIYADH 11426

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ALHAMDAN, Omar Abdulaziz H Riyadh, SA 1 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation